Mr. Pradeep Albert reports

VESALIUS LONGEVITY LABS ANNOUNCES COMMENCEMENT OF TRADING ON THE CANADIAN SECURITIES EXCHANGE UNDER THE SYMBOL "VLAB"

Further to the news releases dated March 4, 2025, June 18, 2025, Feb. 6, 2026, March 11, 2026, Sept. 3, 2026, and Oct. 29, 2026, Vesalius Longevity Labs Inc. (formerly Sweet Earth Holdings Corp.) will commence trading on the Canadian Securities Exchange under the symbol VLAB on Nov. 12, 2026.

Additional information on the company and the business of Vesalius can be found in the company's listing statement dated Nov. 9, 2026, as filed on SEDAR+.

About Vesalius Longevity Labs Inc.

Vesalius Longevity Labs is a longevity science and regenerative health platform focused on being the trusted seed-to-brand partner across the consumer journey for peptide therapeutics, biologics and preventative health care. Vesalius operates a scalable B2Doctor2Consumer ecosystem designed to support health care providers and telehealth infrastructure. Vesalius will manufacture under its Peptual brand Made-in-the-USA peptide APIs (active pharmaceutical ingredients) for domestic and international compounding supply chains. Vesalius's expanding ecosystem includes regenerative medicine, multifaceted compounding pharmacy initiatives, biologics partnerships and advanced artificial-intelligence-powered technologies designed to support the future of personalized health and wellness.

We seek Safe Harbor.